Recruiting Leukemia Studies in Richmond
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
This is a Phase 1/2, global multicentre, open-label, single-arm, dose escalation and dose optimisation study of AZD0486 to evaluate the safety, tolerability, and efficacy of AZD0486 monotherapy in par...
Selinexor With Combination With Induction/Consolidation Therapy in Acute Myeloid Leukemia Patients
This pilot phase II trial studies how well selinexor works when given together with induction, consolidation, and maintenance therapy in treating older patients with acute myeloid leukemia. Selinexor ...
About Leukemia Clinical Trials in Richmond
Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.
There are currently 2 leukemia clinical trials recruiting participants in Richmond, VIRGINIA. These studies are seeking a combined 206 participants. Research is being sponsored by AstraZeneca, Wake Forest University Health Sciences. Clinical trial participation is free and participants receive study-related medical care at no cost.
Leukemia Clinical Trials in Richmond — FAQ
Are there leukemia clinical trials in Richmond?
Yes, there are 2 leukemia clinical trials currently recruiting in Richmond, VIRGINIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Richmond?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Richmond research site will contact you about next steps.
Are clinical trials in Richmond free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Richmond studies also compensate for your time and travel.
What leukemia treatments are being tested?
The 2 active trials in Richmond are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.
Data updated March 2, 2026 from ClinicalTrials.gov